Filter
1479
Filtered Results: 1479
Text search:
World
Health
Organization
(Regional
Office
for
South-East-Asia)
Featured
Recommendations
137
New Publications
388
Language
Document type
No document type
763
Studies & Reports
345
Guidelines
178
Manuals
76
Strategic & Response Plan
55
Training Material
16
Situation Updates
15
Fact sheets
13
Resource Platforms
9
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
97
South–East Asia Region
67
India
58
Myanmar / Burma
57
Nepal
44
Asia
42
Philippines
29
Bangladesh
26
Western and Central Europe
25
Indonesia
22
Africa
21
Cambodia
16
Ethiopia
14
Uganda
14
Western Pacific Region
14
Kenya
12
Thailand
12
Syria
11
Pakistan
10
Middle East and North Africa
10
Liberia
9
Afghanistan
9
Eastern Europe
9
Tanzania
8
South Africa
8
Zambia
7
Ukraine
7
Haiti
6
Mozambique
6
Sri Lanka
6
Yemen
6
Laos
6
Sierra Leone
5
Nigeria
5
Congo, Democratic Republic of
5
Ghana
5
Somalia
5
China
5
Rwanda
5
Malawi
5
East and Southern Africa
5
West and Central Africa
5
Latin America and the Carribbean
5
Russia
5
Zimbabwe
4
South Sudan
4
Sudan
4
Venezuela
4
Moldova
4
Vietnam
4
Burkina Faso
3
Senegal
3
Jordan
3
Papua New Guinea
3
Central African Republic
3
North Macedonia
3
Eastern Europe and Central Asia
3
Timor Leste/ East Timor
3
Iran
3
Georgia
3
Guinea
2
USA
2
Iraq
2
Lebanon
2
Turkey
2
Malaysia
2
Eswatini/ Swaziland
2
Madagascar
2
Mexico
2
North Korea
2
Albania
2
Kazakhstan
2
Belarus
2
Bosnia and Herzegovina
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Egypt
1
Singapore
1
Vanuatu
1
Argentina
1
Peru
1
Brazil
1
Hungary
1
Croatia
1
Ecuador
1
Greece
1
Lesotho
1
Other region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Tajikistan
1
Qatar
1
Romania
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
161
Public Health
106
Women & Child Health
98
Key Resources
82
Capacity Building
26
Pharmacy & Technologies
18
Toolboxes
HIV
157
Mental Health
127
COVID-19
105
Planetary Health
97
TB
69
Rapid Response
60
NTDs
59
AMR
57
Global Health Education
50
Disability
49
Refugee
39
Caregiver
34
Natural Hazards
31
NCDs
27
Health Financing Toolbox
24
Conflict
23
Pharmacy
20
Zika
16
Ebola
11
Cholera
7
Specific Hazards
7
Polio
6
Typhoon
3
Social Ethics
1
Health Financing
1
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
Water, sanitation and hygiene (WASH) are critical in the prevention and care for all of the 17 neglected tropical diseases (NTDs) scheduled for intensified control or elimination by 2020.
Provi...
Provi...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this docume...
2016 Update
Key population
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular disease...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa....
Sound periodic programme reviews provide opportunities for countries to objectively assess progress and take corrective action to sustain or get back on track towards achieving their medium and long-term programme goals. It reflects people’s diver...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 Octob...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid ant...
Known avoidable environmental risks to health cause at least 12.6 million deaths every year, and account for about one quarter of the global burden of disease (2016 data) (1). Air pollution alone ca...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structu...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and...
Safe drinking-water management must consider drinking-water quality, acceptability and quantity in the context of public health protection. In this manual, the term “safety” encompasses these three elements. Although the principles in this manua...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) ... all people living with HIV.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
